Hantavirus and Andes Virus: WHO Global Monitoring, Prevention, and Latest Updates

The World Health Organization (WHO) is intensifying its global surveillance of hantaviruses, coordinating with multiple nations to better understand the epidemiological characteristics of these zoonotic pathogens. By analyzing how these viruses spread, evolve, and impact human populations across different geographies, health authorities aim to bridge critical gaps in early detection and prevention strategies for diseases that, while rare, often carry high mortality rates.

Hantaviruses represent a complex group of viruses primarily transmitted from rodents to humans. Depending on the strain and the region, they manifest in two primary clinical forms: Hantavirus Pulmonary Syndrome (HPS), predominantly found in the Americas, and Hemorrhagic Fever with Renal Syndrome (HFRS), more common in Europe, and Asia. The current collaborative effort to map these characteristics is vital because hantaviruses often mimic other respiratory or febrile illnesses, leading to dangerous delays in diagnosis.

As a physician and health journalist, I have observed that the challenge with zoonotic spillover—where a virus jumps from animals to humans—is often the lack of standardized global data. The WHO’s push to synchronize data across diverse national health systems is a necessary step toward creating a predictive model for outbreaks, particularly as climate change and urban expansion alter rodent habitats and increase human-wildlife interactions.

The Global Strategy: Understanding Hantavirus Epidemiological Characteristics

The core of the current international effort is to define the epidemiological characteristics of hantaviruses—essentially the “who, where, and how” of the infection. This involves tracking the specific rodent species acting as reservoirs, identifying the environmental triggers that lead to increased shedding of the virus, and analyzing the demographic profiles of those most at risk.

Epidemiological mapping allows scientists to determine if certain strains are becoming more virulent or if the geographic range of the host rodents is expanding. For instance, in North America, the deer mouse is a primary carrier, while in Asia, various species of field mice and voles are implicated. By sharing genomic sequencing and patient data across borders, the WHO can identify whether a sudden cluster of cases is an isolated event or part of a larger regional trend.

This data-sharing initiative is particularly critical for developing nations where diagnostic infrastructure may be limited. When 22 or more countries align their reporting standards, it creates a global “early warning system.” This prevents the scenario where a localized outbreak goes unnoticed until it reaches a critical mass, allowing for faster deployment of medical resources and public health advisories.

Differentiating HPS and HFRS: Two Different Clinical Paths

To understand why the WHO is prioritizing this research, one must understand the two distinct ways hantaviruses attack the human body. Though they share a common origin in rodents, the clinical outcomes differ drastically based on the viral strain.

Hantavirus Pulmonary Syndrome (HPS) is most prevalent in the Americas. We see characterized by a rapid onset of respiratory failure. Patients typically experience flu-like symptoms—fever, muscle aches, and fatigue—which quickly progress to severe shortness of breath as the lungs fill with fluid. According to the Centers for Disease Control and Prevention (CDC), HPS has a high fatality rate, often exceeding 35%, making rapid clinical recognition essential for survival.

Hemorrhagic Fever with Renal Syndrome (HFRS) is the dominant form in Eurasia. This strain targets the kidneys and the vascular system. Symptoms often include high fever, chills, and back pain, progressing to kidney failure and internal bleeding (hemorrhaging). While HFRS generally has a lower mortality rate than HPS, it can cause permanent renal damage if not treated promptly with supportive care or specific immunoglobulins in certain regions.

The distinction between these two syndromes is not merely academic; it dictates the medical response. HPS requires aggressive respiratory support and ventilation, while HFRS requires careful management of fluid balance and renal replacement therapy (dialysis) in severe cases.

Mechanisms of Transmission and the ‘Zoonotic Jump’

Hantaviruses are not transmitted person-to-person in the vast majority of cases. Instead, they rely on a process called aerosolization. Infected rodents shed the virus in their urine, droppings, and saliva. When these materials dry, the virus can become airborne in microscopic particles.

Human infection occurs when a person breathes in these contaminated particles—usually while cleaning out old sheds, barns, or cabins where rodents have nested. This is why “cleaning” is often the most dangerous activity associated with hantavirus. Sweeping a dusty floor with a broom can kick up thousands of viral particles into the air, leading to a high-dose inhalation that triggers severe illness.

A notable and dangerous exception is the Andes virus found in South America (specifically Chile and Argentina). Research indicates that the Andes strain possesses the rare ability for human-to-human transmission, likely through close contact. This characteristic makes the Andes virus a particular point of interest for the WHO, as it transforms a zoonotic disease into a potential communicable one, necessitating stricter quarantine and contact-tracing protocols.

Practical Prevention: Reducing the Risk of Exposure

Because there is no widely available vaccine for most hantaviruses and no specific antiviral cure, prevention is the primary line of defense. The goal is to break the link between the rodent reservoir and the human host.

For those living in or visiting areas known for hantavirus activity, the following guidelines are recommended by global health authorities:

• Seal the Entry Points: The most effective long-term strategy is rodent-proofing homes. This includes sealing holes in walls, floors, and foundations with steel wool or caulk to prevent rodents from entering living spaces.
• Safe Cleaning Practices: Never sweep or vacuum areas where rodent droppings are present, as this aerosolizes the virus. Instead, spray the area with a disinfectant or a mixture of bleach and water. Let it soak for five minutes before wiping it up with paper towels.
• Ventilation: Before entering a confined space that has been closed for a long time (like a cellar or attic), open all doors and windows and allow fresh air to circulate for at least 30 minutes.
• Waste Management: Store food in rodent-proof containers and dispose of trash in sealed bins to avoid attracting wild rodents into the home.

For those in high-risk occupations, such as forestry or agriculture, using N95 respirators when working in dusty, rodent-infested environments provides a critical layer of protection against inhalation.

The Path Toward Diagnosis and Treatment

One of the most frustrating aspects of hantavirus is the “diagnostic lag.” Because the early symptoms—fever, myalgia, and headache—are identical to the common flu or COVID-19, many patients are misdiagnosed during the first few days of illness. By the time the hallmark symptoms (respiratory distress for HPS or renal failure for HFRS) appear, the window for early intervention has often closed.

Modern diagnosis relies on serological testing to detect antibodies or RT-PCR tests to detect the viral RNA in the blood. The WHO is working to standardize these tests so that a clinic in a rural region can achieve the same diagnostic accuracy as a major urban hospital. Early detection allows physicians to move patients to Intensive Care Units (ICUs) faster, where supportive therapies can be administered.

Treatment remains primarily supportive. For HPS, this means early intubation and mechanical ventilation to maintain oxygen levels while the body fights the virus. For HFRS, the focus is on managing blood pressure and supporting kidney function. While some studies have explored the use of ribavirin (an antiviral), its effectiveness is inconsistent and varies by strain, leaving supportive care as the global gold standard according to the World Health Organization.

Why This Matters for Global Health Security

The effort to understand hantavirus epidemiological characteristics is part of a broader strategy known as “One Health.” This approach recognizes that human health is inextricably linked to the health of animals and the shared environment. When we monitor the health of rodent populations, we are essentially monitoring the “pre-emergent” stage of human disease.

As we see more frequent “spillover” events globally, the ability to quickly identify a new strain of hantavirus—or a mutation that allows for easier human-to-human transmission—is a matter of global security. The collaboration between 22 countries serves as a blueprint for how the world can handle other zoonotic threats, from avian influenza to novel coronaviruses.

this research helps in the development of targeted vaccines. While a few vaccines exist for specific HFRS strains in China and Russia, a universal hantavirus vaccine remains elusive due to the genetic diversity of the virus. Mapping the epidemiological characteristics allows researchers to identify the most common “conserved” parts of the virus that could be targeted by a vaccine.

The next phase of this international effort will likely focus on the integration of real-time genomic surveillance, allowing health officials to track the virus’s evolution in real-time. As the WHO continues to synthesize data from its partner nations, the goal remains clear: to transform hantavirus from a mysterious and deadly threat into a manageable and preventable public health challenge.

We invite our readers to share this information with those living in rural or high-risk areas. If you have questions about zoonotic diseases or would like to see more coverage on global health surveillance, please leave a comment below or share this article on your social platforms.